Condition: Mandibular Reconstruction · Segmental Mandibular Defects · Sponsor: AO Innovation Translation Center
Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.
This description comes directly from the study's public registry record.
Maria Medina Giner · 0795456120 · maria.medinaginer@aofoundation.org
Marco Minoia, PhD · marco.minoia@aofoundation.org
Always discuss trial participation with your own doctor first.
| University of Florida College of Medicine | Jacksonville, Florida, United States | Recruiting |
| University of Illinois Chicago | Chicago, Illinois, United States | Recruiting |
| Northwell Health Cancer Institute | New Hyde Park, New York, United States | Not Yet Recruiting |
| Mount Sinai Hospital | New York, New York, United States | Recruiting |
| John Peter Smith Health Network | Fort Worth, Texas, United States | Recruiting |
| Universitätsklinikum Tübingen | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
| University Hospital RWTH Aachen | Aachen, Germany | Recruiting |
| University Hospital Charité | Berlin, Germany | Recruiting |
| Hannover Medical School | Hanover, Germany | Recruiting |
| Universitätsklinikum Heidelberg | Heidelberg, Germany | Recruiting |
| University Hospital Leipzig | Leipzig, Germany | Recruiting |
| Klinikum der LMU München | Munich, Germany | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04098146